Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.930
+0.030 (1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bluejay Diagnostics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
2.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.27M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.55M |
| Catheter Precision | 819.00K |
| Tivic Health Systems | 482.00K |
BJDX News
- 21 days ago - Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial - GlobeNewsWire
- 6 weeks ago - Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting - GlobeNewsWire
- 6 weeks ago - NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 - GlobeNewsWire
- 4 months ago - Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire